118 related articles for article (PubMed ID: 22933144)
1. Cytokines as potential biomarkers for Parkinson's disease: a multiplex approach.
Litteljohn D; Hayley S
Methods Mol Biol; 2012; 934():121-44. PubMed ID: 22933144
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
3. Depression and Parkinson's disease: a new look at an old problem.
Edwards E; Kitt C; Oliver E; Finkelstein J; Wagster M; McDonald WM
Depress Anxiety; 2002; 16(1):39-48. PubMed ID: 12203670
[TBL] [Abstract][Full Text] [Related]
4. Multiple cytokine biomarkers in heart failure.
Vistnes M; Christensen G; Omland T
Expert Rev Mol Diagn; 2010 Mar; 10(2):147-57. PubMed ID: 20214534
[TBL] [Abstract][Full Text] [Related]
5. Anxiety disorders in Parkinson's disease.
Richard IH
Adv Neurol; 2005; 96():42-55. PubMed ID: 16383211
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with depression in Parkinson's disease.
Dissanayaka NN; Sellbach A; Silburn PA; O'Sullivan JD; Marsh R; Mellick GD
J Affect Disord; 2011 Jul; 132(1-2):82-8. PubMed ID: 21356559
[TBL] [Abstract][Full Text] [Related]
7. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.
Anisman H; Merali Z; Hayley S
Prog Neurobiol; 2008 May; 85(1):1-74. PubMed ID: 18346832
[TBL] [Abstract][Full Text] [Related]
9. Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?
Staines DR
Med Hypotheses; 2007; 69(6):1208-11. PubMed ID: 17562359
[TBL] [Abstract][Full Text] [Related]
10. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and behavioural impairment in Parkinson's disease.
Merims D; Freedman M
Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
[TBL] [Abstract][Full Text] [Related]
12. Depression and cognitive impairment in Parkinson's disease: a role for inflammation and immunomodulation?
Pessoa Rocha N; Reis HJ; Vanden Berghe P; Cirillo C
Neuroimmunomodulation; 2014; 21(2-3):88-94. PubMed ID: 24557040
[TBL] [Abstract][Full Text] [Related]
13. Depressive disorders in Parkinson's disease may be due to a shared immune-mediated neurodegenerative process.
Kummer A; Teixeira AL
Med Hypotheses; 2008; 70(1):201-2. PubMed ID: 17881136
[No Abstract] [Full Text] [Related]
14. Dementia in Parkinson's disease.
Robottom BJ; Weiner WJ
Int Rev Neurobiol; 2009; 84():229-44. PubMed ID: 19501721
[TBL] [Abstract][Full Text] [Related]
15. Mood disorders in Parkinson's disease.
Tan LC
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S74-6. PubMed ID: 22166461
[TBL] [Abstract][Full Text] [Related]
16. [Benchmarking in patient care: depression in Parkinson's disease].
Spottke A; Schneider F; Dodel R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of mental disorders in persons with Parkinson's disease].
de Rijk C; Bijl RV
Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
[TBL] [Abstract][Full Text] [Related]
18. Depression and major depressive disorder in patients with Parkinson's disease.
Inoue T; Kitagawa M; Tanaka T; Nakagawa S; Koyama T
Mov Disord; 2010 Jan; 25(1):44-9. PubMed ID: 20014057
[TBL] [Abstract][Full Text] [Related]
19. Depression in Parkinson's disease: impediments to recognition and treatment options.
Poewe W; Luginger E
Neurology; 1999; 52(7 Suppl 3):S2-6. PubMed ID: 10227602
[TBL] [Abstract][Full Text] [Related]
20. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
